Financhill
Back

OS Therapies Stock Predictions

OS Therapies Stock Forecast

  • Is OS Therapies Stock Undervalued?
    The current OS Therapies [OSTX] share price is $4.90. The Score for OSTX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • OSTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will OS Therapies Stock Go Up Next Year?

Data Unavailable

OS Therapies Stock Rating

Data Unavailable

OS Therapies Stock Price History

Is OSTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OSTX is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ostherapies.com

52-Week Data

52-Week High:
6.48
52-Week Low:
1.58

Prediction Charts

Market Cap:
104.1M
Price in USD:
4.90
Volume:
50.9K
Beta:
-14.88

Technical Analysis

SMA50:
3.02
SMA100:
3.23
SMA200:
0.00
52-Wk Change:
0%

Stock Predictions

  • Is OS Therapies stock public?
    Yes, OS Therapies is a publicly traded company.
  • What is the OS Therapies stock quote today?
    The OS Therapies stock price is 4.90 USD today.
  • How to buy OS Therapies stock online?
    You can buy OS Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-17 3.50 4.71 6.48 3.26
Dec-18 4.56 4.09 4.99 4.04
Dec-19 4.17 3.91 4.51 3.80
Dec-20 3.91 3.97 4.21 3.53
Dec-23 3.97 3.78 4.47 3.65
Dec-24 3.87 3.83 4.46 3.63
Dec-26 3.90 5.11 5.55 3.73
Dec-27 5.59 5.16 5.59 4.41
Dec-30 5.17 4.70 5.93 4.38
Dec-31 4.79 4.28 4.96 3.95
Jan-2 4.60 4.18 4.93 4.01
Jan-3 4.39 4.26 4.53 4.07
Jan-6 4.44 4.76 5.01 4.25
Jan-7 5.00 4.90 5.44 4.90

OS Therapies Earnings

Data Unavailable

OS Therapies Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.19 per share.

* OS Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.